Traded Aug 3, 2026 · Filed Aug 4, 2026
A board member of Northrop Grumman sold $2.2K of Northrop Grumman shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,217
Shares × reported transaction price
13 days after results of Jul 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $548.47 on Aug 3, 2026, 11% above its 52-week low and 29% below its high, after a 5% rise over the previous 30 trading days
52-week range $496.02 (Jun 29, 2026) to $768.02 (Mar 2, 2026), 19% of the way up, from 251 adjusted closes. 30 trading days earlier: $521.50 on Jun 18, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.6% | +0.3% | +3.2% |
| 30 days | -7.6% | +0.1% | -7.7% |
Past results only. Not a forecast.
120mm, advanced multi-purpose (amp) m1147 high explosive multi-purpose with tracer (hemp-t) cartridge
Starts Mar 27, 2026Runs until May 31, 2028
The Department of Defense awarded Northrop Grumman a $159M contract for advanced cartridges. This is the second largest of 10 recent contracts for the company and represents 12% of its new federal contracts this year, making it a significant but routine award after open competition.
Undefinitized contract action for common infrared countermeasure system (circm) full rate production 2 (frp2) and services year 1 delivery…
$120M committed so farcould reach $160M
Starts Jan 28, 2026Runs until Aug 31, 2028
The Department of Defense awarded Northrop Grumman a contract worth $120M so far for producing and servicing an infrared countermeasure system. This contract was awarded without competition and is expected to last about 3 years, making it a significant but planned deal for the company.
Compensation award — excluded from discretionary-purchase analysis.
